Clinical Trials Logo

Clinical Trial Summary

There is currently no real consensus on the optimal management of acute sprains of the proximal interphalangeal joint of the long fingers.

The aim of this study is to assess the beneficial effect of an injection of corticosteroids for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute phase). This treatment, if effective, might become the treatment of choice for these types of injuries, instead of a prolonged immobilization or a careful early mobilization.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02916940
Study type Interventional
Source Brugmann University Hospital
Contact
Status Completed
Phase Phase 2
Start date November 16, 2016
Completion date February 11, 2020

See also
  Status Clinical Trial Phase
Completed NCT00765700 - Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury Phase 3
Recruiting NCT02285868 - ATI Evidence-based Guide Investigating Clinical Services
Withdrawn NCT00954785 - Etoricoxib in Acute Ankle Ligament Sprains Phase 4
Terminated NCT01508728 - Efficacy Study of a Sensory Feedback Knee Orthosis in Patients Suffering From Unoperated Severe Knee Sprain Phase 2
Completed NCT00351104 - Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain Phase 3
Completed NCT00671320 - A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle Phase 4
Not yet recruiting NCT02346786 - Epidemiology of Incidents and Accidents in Sport. Influence of Moisture. Phase 3
Completed NCT00601471 - Effects of Proximal and Distal Tibiofibular Joint Manipulation on Lower Extremity Muscle Activation, Ankle Range of Motion, and Functional Outcome Scores in Individuals With Chronic Ankle Instability N/A
Withdrawn NCT01223053 - Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury Phase 3